Farther Finance Advisors’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.44K Buy
47
+3
+7% +$206 ﹤0.01% 4973
2026
Q1
$2.85K Sell
44
-9
-17% -$625 ﹤0.01% 4756
2025
Q4
$4.21K Buy
53
+46
+657% +$3.89K ﹤0.01% 4395
2025
Q3
$463 Buy
+7
New +$416 ﹤0.01% 4560

Other funds holding IRON

Farther Finance Advisors's IRON Position: Q2 2026 in Review

Farther Finance Advisors increased its Disc Medicine (IRON) stake by 6.8% in Q2 2026, buying an estimated $206 and bringing the position to 47 shares worth $3.44K. The position accounts for ﹤0.01% of the portfolio, ranked #4973.

Farther Finance Advisors first reported a position in IRON in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.21K in Q4 2025. 26 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Farther Finance Advisors held 47 shares of Disc Medicine worth $3.44K as of Q2 2026.
  • Farther Finance Advisors bought 3 Disc Medicine shares in Q2 2026, an estimated $206.
  • Disc Medicine made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4973 holding.
  • Farther Finance Advisors first reported a position in Disc Medicine in Q3 2025 and has held it in 4 quarters since.
  • Farther Finance Advisors's Disc Medicine position peaked at $4.21K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.